-
Mashup Score: 0REGENCY: Obinutuzumab Proves Efficacy in Lupus Nephritis - 5 month(s) ago
Use of obinutuzumab was associated with significant improvements in complete renal response rate and markers of disease activity in active lupus nephritis.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0REGENCY: Obinutuzumab Proves Efficacy in Lupus Nephritis - 5 month(s) ago
Use of obinutuzumab was associated with significant improvements in complete renal response rate and markers of disease activity in active lupus nephritis.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Phase 3 REGENCY trial: Obinutuzumab (Gazyva/Gazyvaro; @Roche) outperforms standard therapy in #LupusNephritis. ✅ 46.4% achieved complete renal response ✅ Improved disease markers & proteinuria ✅ Reduced renal-related events https://t.co/7UvTKX56tR #Rheumatology #Nephrology https://t.co/SYtnYcxjTM
-
Phase 3 REGENCY trial: Obinutuzumab (Gazyva/Gazyvaro; @Roche) outperforms standard therapy in #LupusNephritis. ✅ 46.4% achieved complete renal response ✅ Improved disease markers & proteinuria ✅ Reduced renal-related events https://t.co/7UvTKX56tR #Rheumatology #Nephrology https://t.co/SYtnYcxjTM